BB&T Investment Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

BB&T Investment Services’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$20K	Hold	482	–	–	﹤0.01%	807
2017 Q3	$20K	Hold	482	–	–	﹤0.01%	725
2017 Q2	$20K	Buy	482 +72	+18%	+$3.04K	0.01%	664
2017 Q1	$17K	Buy	410 +46	+13%	+$1.88K	0.01%	623
2016 Q4	$14K	Buy	+364	New	+$14.8K	0.01%	483

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

BB&T Investment Services's XPH Position: Q4 2017 in Review

BB&T Investment Services held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q4 2017 at 482 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #807.

BB&T Investment Services first reported a position in XPH in Q4 2016 and has held it in 5 quarters since. 85 funds tracked by Wall St. Rank hold XPH as of Q4 2017.

BB&T Investment Services held 482 shares of State Street SPDR S&P Pharmaceuticals ETF worth $20K as of Q4 2017.
BB&T Investment Services left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q4 2017.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #807 holding.
BB&T Investment Services first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2016 and has held it in 5 quarters since.
85 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.